½ÃÀ庸°í¼­
»óǰÄÚµå
1768275

¼¼°èÀÇ ÇコÄɾî 꺿 ½ÃÀå ±Ô¸ð, Á¡À¯À², ¾÷°è ºÐ¼® º¸°í¼­ : ÄÄÆ÷³ÍÆ®º°, ¿ëµµº°, Àü°³ Çüź°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, Àü¸Á°ú ¿¹Ãø(2025-2032³â)

Global Healthcare Chatbot Market Size, Share & Industry Analysis Report By Component, By Application, By Deployment, By End-use, By Regional Outlook and Forecast, 2025 - 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: KBV Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 363 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ÇコÄɾî 꺿 ½ÃÀå ±Ô¸ð´Â ¿¹Ãø ±â°£ Áß¿¡ 23.7%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÏ¿© 2032³â±îÁö 62¾ï 2,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹»óµÇ°í ÀÖ½À´Ï´Ù.

Äڷγª19 ÆÒµ¥¹ÍÀ¸·Î ÀÎÇØ Àü ¼¼°è ÀÇ·á ½Ã½ºÅÛÀÌ È¯ÀÚµéÀÇ ¾öû³­ ¹®ÀÇ¿Í Á¦ÇÑµÈ ÀÇ·á ÀÚ¿øÀ¸·Î ¾î·Á¿òÀ» °Þ°í ÀÖ´Â °¡¿îµ¥, ÇコÄɾî 꺿ÀÇ µµÀÔÀÌ ´«¿¡ ¶ç°Ô °¡¼ÓÈ­µÇ¾ú½À´Ï´Ù. ºÀ¼â¿Í »çȸÀû °Å¸®µÎ±â·Î ÀÎÇØ ´ë¸é Áø·á°¡ Á¦ÇѵǴ »óȲ¿¡¼­ 꺿Àº Àû½Ã¿¡ °Ç°­ Á¤º¸, Áõ»ó È®ÀÎ, Áø·á ¾È³»¸¦ ¿øÇϴ ȯÀڵ鿡°Ô ÇʼöÀûÀÎ µðÁöÅРⱸ·Î ºÎ»óÇß½À´Ï´Ù. ÀÌó·³ Äڷγª19 ÆÒµ¥¹ÍÀº 꺿 ½ÃÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù.

½ÃÀå ¼ºÀå ¿äÀÎ

ÇコÄɾî Á¤º¸¿Í ¼­ºñ½º¿¡ ´ëÇÑ Áï°¢ÀûÀÎ Á¢±Ù¿¡ ´ëÇÑ ±â´ë°¡ ³ô¾ÆÁö¸é¼­ ÇコÄɾî 꺿ÀÇ µµÀÔÀÌ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. ¿À´Ã³¯ ȯÀÚµéÀº ±âÁ¸ÀÇ Áø·á ½Ã°£¿¡ ±¸¾Ö¹ÞÁö ¾Ê°í °Ç°­ °ü·Ã Áú¹®, Áø·á ¿¹¾à, º¹¾à ¾Ë¸² µî¿¡ ´ëÇÑ ½Ç½Ã°£ ´äº¯À» ¿øÇϰí ÀÖ½À´Ï´Ù. ÷´Ü AI¿Í ÀÚ¿¬¾î ó¸® ±â´ÉÀ» °®Ãá ÇコÄɾî 꺿Àº 24½Ã°£ Áö¿øÀ» Á¦°øÇÏ¿© »ç¿ëÀÚ°¡ ¾ðÁ¦µç ½Å·ÚÇÒ ¼ö ÀÖ´Â Á¤º¸¿Í Áö¿øÀ» ¹ÞÀ» ¼ö ÀÖµµ·Ï ÇÕ´Ï´Ù. °á·ÐÀûÀ¸·Î, 24/7 ÇコÄÉ¾î ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä´Â ÀÌ ½ÃÀå È®´ëÀÇ Áß¿äÇÑ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù.

¶ÇÇÑ, ÀÇ·á ¼­ºñ½º Á¦°ø¿¡ µû¸¥ ºñ¿ë »ó½ÂÀ¸·Î ÀÎÇØ ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü¿Í ÀÇ·á±â°üÀº ǰÁú ÀúÇÏ ¾øÀÌ ºñ¿ëÀ» Àý°¨ÇÒ ¼ö ÀÖ´Â Çõ½ÅÀûÀÎ ¼Ö·ç¼ÇÀ» ã¾Æ¾ß ÇÏ´Â »óȲ¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ÇコÄɾî 꺿Àº ȯÀÚ Á¢¼ö, ¿¹¾à ¿¹¾à, ¿¹ºñ Áø´Ü°ú °°Àº °ü¸® ¾÷¹«¸¦ ÀÚµ¿È­ÇÔÀ¸·Î½á ºñ¿ë È¿À²ÀûÀÎ ´ë¾ÈÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ÇÁ·Î¼¼½º¸¦ °£¼ÒÈ­ÇÔÀ¸·Î½á 꺿Àº ¸·´ëÇÑ ÀÎÀû ÀÚ¿øÀÇ Çʿ伺À» ÃÖ¼ÒÈ­ÇÏ°í ¿î¿µ ºñ¿ëÀ» Àý°¨ÇÕ´Ï´Ù. µû¶ó¼­ ºñ¿ë È¿À²ÀûÀÎ ÇコÄÉ¾î ¼Ö·ç¼ÇÀÇ Ãß±¸´Â ½ÃÀå ¼ºÀåÀ» °ßÀÎÇÏ´Â Áß¿äÇÑ ¿ä¼Ò·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ

꺿À» ÇコÄÉ¾î ½Ã½ºÅÛ¿¡ ÅëÇÕÇÏ¸é µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã ¹× º¸¾È¿¡ ´ëÇÑ ½É°¢ÇÑ ¹®Á¦°¡ ¹ß»ýÇÕ´Ï´Ù. ÀÌ·¯ÇÑ AI ±â¹Ý µµ±¸´Â º´·Â, °³ÀÎ ½Äº° Á¤º¸, °Ç°­ °ü·Ã ¹®ÀÇ µî ȯÀÚÀÇ ±â¹Ð Á¤º¸¸¦ ´Ù·ç´Â °æ¿ì°¡ ¸¹±â ¶§¹®¿¡ ÀÌ·¯ÇÑ µ¥ÀÌÅÍÀÇ ±â¹Ð¼º°ú ¹«°á¼ºÀ» º¸ÀåÇÏ´Â °ÍÀÌ °¡Àå Áß¿äÇÕ´Ï´Ù. ±×·¯³ª 꺿 ½Ã½ºÅÛ¿¡´Â ¾ÇÀÇÀûÀÎ °ø°ÝÀÚ°¡ ¾Ç¿ëÇÒ ¼ö ÀÖ´Â Ãë¾àÁ¡ÀÌ ÀÖ´Ù´Â ¿¬±¸ °á°ú°¡ ÀÖ½À´Ï´Ù. µû¶ó¼­ ÀÌ·¯ÇÑ ¹®Á¦¸¦ ÇØ°áÇϱâ À§Çؼ­´Â ¾ö°ÝÇÑ µ¥ÀÌÅÍ º¸È£ ÇÁ·ÎÅäÄÝÀÇ ±¸Çö, Á¤±âÀûÀÎ º¸¾È °¨»ç, ±×¸®°í µ¥ÀÌÅÍ Ã³¸®ÀÇ Åõ¸í¼º È®º¸°¡ ÇʼöÀûÀÔ´Ï´Ù.

°¡Ä¡»ç½½ ºÐ¼®

ÀÌ ½ÃÀåÀÇ ¹ë·ùüÀÎ ºÐ¼®Àº Á¾ÇÕÀûÀÎ °³¹ß ¹× Á¦°øÁֱ⸦ °­Á¶ÇÕ´Ï´Ù. ¸ÕÀú ¿¬±¸°³¹ß(R&D)¿¡¼­ ½ÃÀÛÇÏ¿© ÄÁÅÙÃ÷¿Í ÀÇ·á Áö½ÄÀ» 꺿 ½Ã½ºÅÛ¿¡ ÅëÇÕÇÕ´Ï´Ù. ±× ´ÙÀ½¿¡´Â Ç÷§Æû °³¹ß ¹× ÅëÇÕÀÌ ÁøÇàµÇ¾î ±â¼ú ÀÎÇÁ¶ó¸¦ ±¸ÃàÇÕ´Ï´Ù. ´ÙÀ½ ´Ü°è¿¡¼­´Â »ç¿ëÀÚ °æÇè(UX)°ú ÀÎÅÍÆäÀ̽º ¼³°è¿¡ ÁýÁßÇÏ¿© »ç¿ë¼ºÀ» °³¼±Çϰí, ±ÔÁ¦ ±âÁØÀ» ÃæÁ·Çϱâ À§ÇÑ µ¥ÀÌÅÍ º¸¾È ¹× ÄÄÇöóÀ̾𽺠°ü¸®¿Í ±ÔÁ¦ Áؼö¿¡ ÁýÁßÇÕ´Ï´Ù. ÀÌ ÇÁ·Î¼¼½º´Â ¸¶ÄÉÆÃ°ú °í°´ È®º¸·Î À̾îÁö¸ç, ÆÇ¸Å¿Í À¯ÅëÀ¸·Î À̾îÁý´Ï´Ù. µµÀÔ ÈÄ ´Ü°è¿¡´Â ±¸Çö ¹× ¸ÂÃã ¼­ºñ½º, ¸ð´ÏÅ͸µ ¹× ºÐ¼®, Áö¼ÓÀûÀÎ À¯Áöº¸¼ö ¹× ¾÷±×·¹À̵尡 Æ÷ÇԵǸç, ÃÖÁ¾ÀûÀ¸·Î R&D·Î µ¹¾Æ°¡ Áö¼ÓÀûÀÎ Çõ½ÅÀ¸·Î À̾îÁý´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼®

ÄÄÆ÷³ÍÆ® Àü¸Á

±¸¼º ¿ä¼Ò¿¡ µû¶ó ½ÃÀåÀº ¼ÒÇÁÆ®¿þ¾î ¹× ¼­ºñ½º·Î ºÐ·ùµË´Ï´Ù. ¼ÒÇÁÆ®¿þ¾î¿¡´Â AI ¾Ë°í¸®Áò, NLP ¿£Áø, 꺿 ÀÎÅÍÆäÀ̽º°¡ Æ÷ÇԵǸç, ¼­ºñ½º¿¡´Â µµÀÔ, ÅëÇÕ, ±³À°, À¯Áöº¸¼ö°¡ Æ÷ÇԵ˴ϴÙ. ¼­ºñ½º ºÎ¹®Àº 2024³â 37%ÀÇ ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¼¼°è ½ÃÀå¿¡¼­ ¼­ºñ½º´Â ¿øÈ°ÇÑ ±¸Çö°ú Àå±âÀûÀÎ ±â´É¼ºÀ» º¸ÀåÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ¿©±â¿¡´Â ¸ÂÃãÇü °³¹ß, ½Ã½ºÅÛ ÅëÇÕ, API °ü¸®, º¿ÀÇ È¿°úÀûÀÎ »ç¿ëÀ» À§ÇÑ Á÷¿ø ±³À°, Áö¼ÓÀûÀÎ ºÐ¼® ¹× ¼º´É ÃÖÀûÈ­ Á¦°ø µîÀÌ Æ÷ÇԵ˴ϴÙ.

¿ëµµ Àü¸Á

À¯·´ ÇコÄɾî 꺿 ½ÃÀåÀº ¿ëµµº°·Î ÀÇ·á µ¥ÀÌÅÍ ÀúÀå¼Ò, ÀÚµ¿ ȯÀÚ Áö¿ø, °³ÀÎ Áö¿ø, ±âŸ ¿ëµµ·Î ºÐ·ùµË´Ï´Ù. ÀÚµ¿ ȯÀÚ Áö¿ø ºÎ¹®Àº 2024³â 29%ÀÇ ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿¹¾à °ü¸®, °Ë»ç °á°ú Àü´Þ, Áõ»ó ºÐ·ù, ¿¹¹æÁ¢Á¾ ¾Ë¸²°ú °°Àº ÀÚµ¿È­µÈ 꺿 ±â´ÉÀº ÇöÀç Àü ¼¼°èÀûÀ¸·Î ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â´ÉÀº 24/7 ¼¿ÇÁ ¼­ºñ½º ¿É¼ÇÀ» Á¦°øÇÔÀ¸·Î½á °ü¸® ¾÷¹«ÀÇ ºÎ´ãÀ» Å©°Ô ÁÙÀ̰í ȯÀÚ ¸¸Á·µµ¸¦ Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù.

Àü°³ Àü¸Á

¹èÆ÷¿¡ µû¶ó ÇコÄɾî 꺿 ½ÃÀåÀº Ŭ¶ó¿ìµå ¸ðµ¨°ú On-Premise ¸ðµ¨·Î ºÐ·ùµÇ¸ç, °¢±â ´Ù¸¥ ¿î¿µ ¹× ±ÔÁ¦ ¿ä±¸ »çÇ׿¡ µû¶ó ºÐ·ùµË´Ï´Ù. On-Premise ºÎ¹®Àº 2024³â 36%ÀÇ ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. On-Premise ±¸ÃàÀº µ¥ÀÌÅÍ¿¡ ´ëÇÑ ¿ÏÀüÇÑ Á¦¾î°¡ ¿ä±¸µÇ´Â ȯ°æ¿¡¼­ ¿©ÀüÈ÷ Áß¿äÇÕ´Ï´Ù. ÀÌ ¸ðµ¨Àº ¾ö°ÝÇÑ µ¥ÀÌÅÍ ·¹Áö´ø½Ã, ÇÁ¶óÀ̹ö½Ã, ½Ã½ºÅÛ Ä¿½ºÅ͸¶ÀÌ¡À» Áö¿øÇϸç, À¯·´°ú °°ÀÌ ±ÔÁ¦°¡ ¾ö°ÝÇÑ Áö¿ªÀÇ ±â°ü, Á¤ºÎ ±â°ü, ±¹¹æ ±â°ü µî ÇコÄÉ¾î ºÐ¾ß¿¡¼­ ¼±È£µÇ°í ÀÖ½À´Ï´Ù.

ÃÖÁ¾ ¿ëµµ Àü¸Á

ÇコÄɾî 꺿 ½ÃÀåÀº ÃÖÁ¾ »ç¿ëÀÚº°·Î ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü, ȯÀÚ, º¸Çè»ç, ±âŸ ÃÖÁ¾ »ç¿ëÀÚ·Î ºÐ·ùµË´Ï´Ù. ȯÀÚ ºÎ¹®Àº 2024³â 22%ÀÇ ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Àü ¼¼°è ȯÀÚµéÀº ¸ð¹ÙÀÏ Ãªº¿ Ç÷§ÆûÀ» ÅëÇØ ¿Âµð¸Çµå ¹æ½ÄÀ¸·Î ÀÇ·á ¼­ºñ½º¸¦ ÀÌ¿ëÇÒ ¼ö ÀÖ´Ù´Â ÀÌÁ¡À» ´©¸®°í ÀÖ½À´Ï´Ù. ¸¸¼ºÁúȯ °ü¸®, Á¤½Å °Ç°­ Áö¿ø(Woebot, Wysa µî) ÀÌ¿ë, Áõ»ó ÇØ¼® µî 꺿Àº »ç¿ëÀÚ°¡ ½º½º·Î °Ç°­À» °ü¸®ÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù.

Áö¿ª Àü¸Á

Áö¿ªº°·Î´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«·Î ±¸ºÐµË´Ï´Ù. À¯·´Àº 2024³â 35.92% ½ÃÀå Á¡À¯À²À» ±â·ÏÇß½À´Ï´Ù. ÀÌ·¯ÇÑ ¼ºÀåÀº ÇコÄÉ¾î ¼­ºñ½ºÀÇ µðÁöÅÐÈ­ ÁøÀü°ú ÀÌ Áö¿ªÀÇ ÀΰøÁö´É ±â¼úÀÇ ±¤¹üÀ§ÇÑ µµÀÔ¿¡ ±âÀÎÇÕ´Ï´Ù. ¶ÇÇÑ, ¿©·¯ ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ Á¸Àç, °­·ÂÇÑ ÀÇ·á ÀÎÇÁ¶ó, ȯÀÚ Âü¿©¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ÇコÄɾî 꺿ÀÇ µµÀÔÀÌ ´õ¿í °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ½ÃÀå ¹üÀ§¿Í Á¶»ç ¹æ¹ý

  • ½ÃÀåÀÇ Á¤ÀÇ
  • ¸ñÀû
  • ½ÃÀå ¹üÀ§
  • ¼¼ºÐÈ­
  • Á¶»ç ¹æ¹ý

Á¦2Àå ½ÃÀå °³°ü

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®

Á¦3Àå ½ÃÀå °³¿ä

  • ¼­·Ð
    • °³¿ä
  • ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¿äÀÎ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ½ÃÀå ±âȸ
    • ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦

Á¦4Àå °æÀï ºÐ¼® - ¼¼°è

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2024³â
  • PorterÀÇ Five Forces ºÐ¼®

Á¦5Àå ÇコÄɾî 꺿 ½ÃÀå ¹ë·ùüÀÎ ºÐ¼®

  • ¿¬±¸°³¹ß(R&D)
  • ÄÁÅÙÃ÷ ¹× ÀÇÇÐ Áö½Ä ÅëÇÕ
  • Ç÷§Æû °³¹ß°ú ÅëÇÕ
  • »ç¿ëÀÚ °æÇè(UX) ¹× ÀÎÅÍÆäÀ̽º µðÀÚÀÎ
  • µ¥ÀÌÅÍ º¸¾È ¹× ÄÄÇöóÀ̾𽺠°ü¸®
  • ¸¶ÄÉÆÃ ¹× °í°´ ȹµæ
  • ÆÇ¸Å ¹× À¯Åë
  • ±¸Çö ¹× Ä¿½ºÅ͸¶ÀÌÁî ¼­ºñ½º
  • ¸ð´ÏÅ͸µ ¹× ºÐ¼®
  • À¯Áö°ü¸® ¹× ¾÷±×·¹À̵å

Á¦6Àå ¼¼°è ½ÃÀåÀÇ ÁÖ¿ä °í°´ ±âÁØ

  • Á¤È®¼º°ú ÀÇÇÐÀû ½Å·Ú¼º
  • µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã¿Í ÄÄÇöóÀ̾ð½º
  • ÅëÇÕ ±â´É
  • ´Ù¾ð¾î/´Ù¹®È­ ÀûÀÀ·Â
  • ºñ¿ë È¿À²°ú ROI
  • »ç¿ëÀÚ °æÇè°ú Á¢±Ù¼º

Á¦7Àå ¼¼°èÀÇ ÇコÄɾî 꺿 ½ÃÀå : ÄÄÆ÷³ÍÆ®º°

  • ¼¼°èÀÇ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : Áö¿ªº°
  • ¼¼°èÀÇ ¼­ºñ½º ½ÃÀå : Áö¿ªº°

Á¦8Àå ¼¼°èÀÇ ÇコÄɾî 꺿 ½ÃÀå : ¿ëµµº°

  • ¼¼°èÀÇ ÀÇ·á µ¥ÀÌÅÍ ¸®Æ÷ÁöÅ丮 ½ÃÀå : Áö¿ªº°
  • ¼¼°èÀÇ ÀÚµ¿ ȯÀÚ Áö¿ø ½ÃÀå : Áö¿ªº°
  • ¼¼°èÀÇ ÆÛ½º³Î ¾î½Ã½ºÅϽº ½ÃÀå : Áö¿ªº°
  • ¼¼°èÀÇ ±âŸ ¿ëµµ ½ÃÀå : Áö¿ªº°

Á¦9Àå ¼¼°èÀÇ ÇコÄɾî 꺿 ½ÃÀå : Àü°³ Çüź°

  • ¼¼°èÀÇ Å¬¶ó¿ìµå ½ÃÀå : Áö¿ªº°
  • ¼¼°èÀÇ On-Premise ½ÃÀå : Áö¿ªº°

Á¦10Àå ¼¼°èÀÇ ÇコÄɾî 꺿 ½ÃÀå : ÃÖÁ¾ ¿ëµµº°

  • ¼¼°èÀÇ ÀÇ·á Á¦°øÀÚ ½ÃÀå : Áö¿ªº°
  • ¼¼°èÀÇ È¯ÀÚ ½ÃÀå : Áö¿ªº°
  • ¼¼°èÀÇ º¸Çèȸ»ç ½ÃÀå : Áö¿ªº°
  • ¼¼°èÀÇ ±âŸ ÃÖÁ¾ ¿ëµµ ½ÃÀå : Áö¿ªº°

Á¦11Àå ¼¼°èÀÇ ÇコÄɾî 꺿 ½ÃÀå : Áö¿ªº°

  • ºÏ¹Ì
    • ºÏ¹ÌÀÇ ÇコÄɾî 꺿 ½ÃÀå : ±¹°¡º°
      • ¹Ì±¹
      • ij³ª´Ù
      • ¸ß½ÃÄÚ
      • ±âŸ ºÏ¹Ì
  • À¯·´
    • À¯·´ÀÇ ÇコÄɾî 꺿 ½ÃÀå : ±¹°¡º°
      • µ¶ÀÏ
      • ¿µ±¹
      • ÇÁ¶û½º
      • ·¯½Ã¾Æ
      • ½ºÆäÀÎ
      • ÀÌÅ»¸®¾Æ
      • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÇコÄɾî 꺿 ½ÃÀå : ±¹°¡º°
      • Áß±¹
      • ÀϺ»
      • Àεµ
      • Çѱ¹
      • ½Ì°¡Æ÷¸£
      • ¸»·¹À̽þÆ
      • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÇコÄɾî 꺿 ½ÃÀå : ±¹°¡º°
      • ºê¶óÁú
      • ¾Æ¸£ÇîÆ¼³ª
      • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
      • »ç¿ìµð¾Æ¶óºñ¾Æ
      • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
      • ³ªÀÌÁö¸®¾Æ
      • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦12Àå ±â¾÷ °³¿ä

  • Ada Health GmbH
  • Healthily LTD
  • Babylon Healthcare Services Ltd(eMed)
  • Woebot Labs, Inc(Woebot Health)
  • TECKEL MEDICAL SL.(Mediktor)
  • HealthTap, Inc
  • Luka, Inc(Replika)
  • K Health, Inc
  • BytePlus Pte Ltd
  • Fabric Labs, Inc(Fabric)

Á¦13Àå ÇコÄɾî 꺿 ½ÃÀåÀ» À§ÇÑ ¼º°ø Çʼö Á¶°Ç

LSH 25.07.21

The Global Healthcare Chatbot Market size is expected to reach $6.22 billion by 2032, rising at a market growth of 23.7% CAGR during the forecast period.

These platforms are widely used across the U.S., UK, China, and India, where chatbot implementation supports both patient-facing and internal healthcare operations. Cloud-based models dominate the software segment globally due to their scalability and rapid deployment capabilities.

COVID 19 Impact Analysis

The COVID-19 pandemic significantly accelerated the adoption of healthcare chatbots as healthcare systems worldwide grappled with overwhelming patient inquiries and limited medical resources. As lockdowns and social distancing mandates disrupted in-person consultations, chatbots emerged as an essential digital front door for patients seeking timely health information, symptom checks, and care guidance. Thus, the COVID-19 pandemic had a positive impact on the market.

Market Growth Factors

The increasing expectation for immediate access to healthcare information and services has significantly fueled the adoption of healthcare chatbots. Patients today seek real-time responses to their health-related queries, appointment scheduling, and medication reminders without the constraints of traditional office hours. Healthcare chatbots, powered by advanced AI and natural language processing, provide round-the-clock assistance, ensuring that users can access reliable information and support at any time. In conclusion, the demand for 24/7 healthcare services continues to be a significant driver in the expansion of this market.

Additionally, the escalating costs associated with healthcare delivery have prompted providers and institutions to seek innovative solutions that can reduce expenses without compromising quality. Healthcare chatbots offer a cost-effective alternative by automating administrative tasks such as patient intake, appointment scheduling, and preliminary diagnostics. By streamlining these processes, chatbots minimize the need for extensive human resources, thereby lowering operational costs. Hence, Consequently, the pursuit of cost-effective healthcare solutions remains a pivotal factor driving the growth of the market.

Market Restraining Factors

The integration of chatbots into healthcare systems introduces significant challenges related to data privacy and security. These AI-driven tools often handle sensitive patient information, including medical histories, personal identifiers, and health-related queries. Ensuring the confidentiality and integrity of this data is paramount. However, studies have highlighted vulnerabilities in chatbot systems that could be exploited by malicious actors. Therefore, addressing these concerns requires implementing stringent data protection protocols, regular security audits, and ensuring transparency in data handling practices.

Value Chain Analysis

The value chain analysis of this Market highlights a comprehensive development and delivery cycle. It begins with Research & Development (R&D), followed by content and medical knowledge integration into the chatbot system. This is succeeded by platform development and integration, ensuring technical infrastructure readiness. The next stage focuses on user experience (UX) and interface design to enhance usability, along with data security and compliance management to meet regulatory standards. The process continues with marketing and customer acquisition, supported by sales and distribution. Post-deployment stages include implementation and customization services, monitoring and analytics, and continuous maintenance and upgrades, looping back into R&D for ongoing innovation.

Market Share Analysis

Component Outlook

Based on Component, the Market is segmented into Software and Services, where software includes AI algorithms, NLP engines, and chatbot interfaces, and services encompass deployment, integration, training, and maintenance. The Services segment acquired 37% revenue share in 2024. Services in the global market play a pivotal role in ensuring seamless implementation and long-term functionality. These include custom development, systems integration, API management, training staff to use bots effectively, and offering ongoing analytics and performance optimization.

Application Outlook

Based on Application, the Healthcare Chatbot Market in Europe is segmented into Medical Data Repositories, Automated Patient Support, Personal Assistance, and Other Applications. Automated Patient Support segment attained 29% revenue share in 2024. Automated chatbot functions such as appointment scheduling, test result delivery, symptom triage, and vaccination reminders are now widespread globally. They significantly reduce administrative workloads and improve patient satisfaction by offering 24/7 self-service options.

Deployment Outlook

Based on Deployment, the Global Healthcare Chatbot Market is segmented into Cloud and On-Premises models, each catering to different operational and regulatory needs. The On-premises segment acquired 36% revenue share in 2024. On-premises deployment remains crucial in environments requiring full control over data. Often preferred by institutions in highly regulated regions like Europe, and in government or defense healthcare settings, this model supports strict data residency, privacy, and system customization.

End-use Outlook

Based on End Use, the Healthcare Chatbot Market is segmented into Healthcare Providers, Patients, Insurance Companies, and Other End Users. The Patients segment witnessed 22% revenue share in 2024. Patients across continents benefit from on-demand access to healthcare services through mobile chatbot platforms. Whether managing chronic diseases, accessing mental health support (e.g., Woebot, Wysa), or interpreting symptoms, chatbots empower users to take control of their health.

Regional Outlook

Region-wise, the market is segmented into North America, Europe, Asia-Pacific, and LAMEA. The Europe segment recorded 35.92% revenue share in the market in 2024. This growth can be attributed to the increasing digitalization of healthcare services and the widespread adoption of artificial intelligence technologies within the region. In addition, the presence of several key market players, strong healthcare infrastructure, and a growing emphasis on patient engagement have further fueled the adoption of healthcare chatbots.

List of Key Companies Profiled

  • Ada Health GmbH
  • Healthily LTD.
  • Babylon Healthcare Services Ltd. (eMed)
  • Woebot Labs, Inc. (Woebot Health)
  • TECKEL MEDICAL S.L. (Mediktor)
  • HealthTap, Inc.
  • Luka, Inc. (Replika)
  • K Health, Inc.
  • BytePlus Pte Ltd.
  • Fabric Labs, Inc. (Fabric)

Global Healthcare Chatbot Market Report Segmentation

By Component

  • Software
  • Services

By Application

  • Medical Data Repositories
  • Automated patient support
  • Personal Assistance
  • Other Application

By Deployment

  • Cloud
  • On-Premises

By End-use

  • Healthcare providers
  • Patients
  • Insurance companies
  • Other End-use

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Healthcare Chatbot Market, by Component
    • 1.4.2 Global Healthcare Chatbot Market, by Application
    • 1.4.3 Global Healthcare Chatbot Market, by Deployment
    • 1.4.4 Global Healthcare Chatbot Market, by End-use
    • 1.4.5 Global Healthcare Chatbot Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
    • 3.2.3 Market Opportunities
    • 3.2.4 Market Challenges

Chapter 4. Competition Analysis - Global

  • 4.1 Market Share Analysis, 2024
  • 4.2 Porter Five Forces Analysis

Chapter 5. Value Chain Analysis of Healthcare Chatbot Market

  • 5.1 Research & Development (R&D)
  • 5.2 Content and Medical Knowledge Integration
  • 5.3 Platform Development and Integration
  • 5.4 User Experience (UX) and Interface Design
  • 5.5 Data Security and Compliance Management
  • 5.6 Marketing and Customer Acquisition
  • 5.7 Sales and Distribution
  • 5.8 Implementation and Customization Services
  • 5.9 Monitoring and Analytics
  • 5.10. Maintenance and Upgrades

Chapter 6. Key Customer Criteria of Global Healthcare Chatbot Market

  • 6.1 Accuracy and Medical Reliability
  • 6.2 Data Privacy and Compliance
  • 6.3 Integration Capabilities
  • 6.4 Multilingual and Cultural Adaptability
  • 6.5 Cost Efficiency and ROI
  • 6.6 User Experience and Accessibility

Chapter 7. Global Healthcare Chatbot Market by Component

  • 7.1 Global Software Market by Region
  • 7.2 Global Services Market by Region

Chapter 8. Global Healthcare Chatbot Market by Application

  • 8.1 Global Medical Data Repositories Market by Region
  • 8.2 Global Automated patient support Market by Region
  • 8.3 Global Personal Assistance Market by Region
  • 8.4 Global Other Application Market by Region

Chapter 9. Global Healthcare Chatbot Market by Deployment

  • 9.1 Global Cloud Market by Region
  • 9.2 Global On-Premises Market by Region

Chapter 10. Global Healthcare Chatbot Market by End-use

  • 10.1 Global Healthcare providers Market by Region
  • 10.2 Global Patients Market by Region
  • 10.3 Global Insurance companies Market by Region
  • 10.4 Global Other End-use Market by Region

Chapter 11. Global Healthcare Chatbot Market by Region

  • 11.1 North America Healthcare Chatbot Market
    • 11.1.1 North America Healthcare Chatbot Market by Component
      • 11.1.1.1 North America Software Market by Region
      • 11.1.1.2 North America Services Market by Region
    • 11.1.2 North America Healthcare Chatbot Market by Application
      • 11.1.2.1 North America Medical Data Repositories Market by Country
      • 11.1.2.2 North America Automated patient support Market by Country
      • 11.1.2.3 North America Personal Assistance Market by Country
      • 11.1.2.4 North America Other Application Market by Country
    • 11.1.3 North America Healthcare Chatbot Market by Deployment
      • 11.1.3.1 North America Cloud Market by Country
      • 11.1.3.2 North America On-Premises Market by Country
    • 11.1.4 North America Healthcare Chatbot Market by End-use
      • 11.1.4.1 North America Healthcare providers Market by Country
      • 11.1.4.2 North America Patients Market by Country
      • 11.1.4.3 North America Insurance companies Market by Country
      • 11.1.4.4 North America Other End-use Market by Country
    • 11.1.5 North America Healthcare Chatbot Market by Country
      • 11.1.5.1 US Healthcare Chatbot Market
        • 11.1.5.1.1 US Healthcare Chatbot Market by Component
        • 11.1.5.1.2 US Healthcare Chatbot Market by Application
        • 11.1.5.1.3 US Healthcare Chatbot Market by Deployment
        • 11.1.5.1.4 US Healthcare Chatbot Market by End-use
      • 11.1.5.2 Canada Healthcare Chatbot Market
        • 11.1.5.2.1 Canada Healthcare Chatbot Market by Component
        • 11.1.5.2.2 Canada Healthcare Chatbot Market by Application
        • 11.1.5.2.3 Canada Healthcare Chatbot Market by Deployment
        • 11.1.5.2.4 Canada Healthcare Chatbot Market by End-use
      • 11.1.5.3 Mexico Healthcare Chatbot Market
        • 11.1.5.3.1 Mexico Healthcare Chatbot Market by Component
        • 11.1.5.3.2 Mexico Healthcare Chatbot Market by Application
        • 11.1.5.3.3 Mexico Healthcare Chatbot Market by Deployment
        • 11.1.5.3.4 Mexico Healthcare Chatbot Market by End-use
      • 11.1.5.4 Rest of North America Healthcare Chatbot Market
        • 11.1.5.4.1 Rest of North America Healthcare Chatbot Market by Component
        • 11.1.5.4.2 Rest of North America Healthcare Chatbot Market by Application
        • 11.1.5.4.3 Rest of North America Healthcare Chatbot Market by Deployment
        • 11.1.5.4.4 Rest of North America Healthcare Chatbot Market by End-use
  • 11.2 Europe Healthcare Chatbot Market
    • 11.2.1 Europe Healthcare Chatbot Market by Component
      • 11.2.1.1 Europe Software Market by Country
      • 11.2.1.2 Europe Services Market by Country
    • 11.2.2 Europe Healthcare Chatbot Market by Application
      • 11.2.2.1 Europe Medical Data Repositories Market by Country
      • 11.2.2.2 Europe Automated patient support Market by Country
      • 11.2.2.3 Europe Personal Assistance Market by Country
      • 11.2.2.4 Europe Other Application Market by Country
    • 11.2.3 Europe Healthcare Chatbot Market by Deployment
      • 11.2.3.1 Europe Cloud Market by Country
      • 11.2.3.2 Europe On-Premises Market by Country
    • 11.2.4 Europe Healthcare Chatbot Market by End-use
      • 11.2.4.1 Europe Healthcare providers Market by Country
      • 11.2.4.2 Europe Patients Market by Country
      • 11.2.4.3 Europe Insurance companies Market by Country
      • 11.2.4.4 Europe Other End-use Market by Country
    • 11.2.5 Europe Healthcare Chatbot Market by Country
      • 11.2.5.1 Germany Healthcare Chatbot Market
        • 11.2.5.1.1 Germany Healthcare Chatbot Market by Component
        • 11.2.5.1.2 Germany Healthcare Chatbot Market by Application
        • 11.2.5.1.3 Germany Healthcare Chatbot Market by Deployment
        • 11.2.5.1.4 Germany Healthcare Chatbot Market by End-use
      • 11.2.5.2 UK Healthcare Chatbot Market
        • 11.2.5.2.1 UK Healthcare Chatbot Market by Component
        • 11.2.5.2.2 UK Healthcare Chatbot Market by Application
        • 11.2.5.2.3 UK Healthcare Chatbot Market by Deployment
        • 11.2.5.2.4 UK Healthcare Chatbot Market by End-use
      • 11.2.5.3 France Healthcare Chatbot Market
        • 11.2.5.3.1 France Healthcare Chatbot Market by Component
        • 11.2.5.3.2 France Healthcare Chatbot Market by Application
        • 11.2.5.3.3 France Healthcare Chatbot Market by Deployment
        • 11.2.5.3.4 France Healthcare Chatbot Market by End-use
      • 11.2.5.4 Russia Healthcare Chatbot Market
        • 11.2.5.4.1 Russia Healthcare Chatbot Market by Component
        • 11.2.5.4.2 Russia Healthcare Chatbot Market by Application
        • 11.2.5.4.3 Russia Healthcare Chatbot Market by Deployment
        • 11.2.5.4.4 Russia Healthcare Chatbot Market by End-use
      • 11.2.5.5 Spain Healthcare Chatbot Market
        • 11.2.5.5.1 Spain Healthcare Chatbot Market by Component
        • 11.2.5.5.2 Spain Healthcare Chatbot Market by Application
        • 11.2.5.5.3 Spain Healthcare Chatbot Market by Deployment
        • 11.2.5.5.4 Spain Healthcare Chatbot Market by End-use
      • 11.2.5.6 Italy Healthcare Chatbot Market
        • 11.2.5.6.1 Italy Healthcare Chatbot Market by Component
        • 11.2.5.6.2 Italy Healthcare Chatbot Market by Application
        • 11.2.5.6.3 Italy Healthcare Chatbot Market by Deployment
        • 11.2.5.6.4 Italy Healthcare Chatbot Market by End-use
      • 11.2.5.7 Rest of Europe Healthcare Chatbot Market
        • 11.2.5.7.1 Rest of Europe Healthcare Chatbot Market by Component
        • 11.2.5.7.2 Rest of Europe Healthcare Chatbot Market by Application
        • 11.2.5.7.3 Rest of Europe Healthcare Chatbot Market by Deployment
        • 11.2.5.7.4 Rest of Europe Healthcare Chatbot Market by End-use
  • 11.3 Asia Pacific Healthcare Chatbot Market
    • 11.3.1 Asia Pacific Healthcare Chatbot Market by Component
      • 11.3.1.1 Asia Pacific Software Market by Country
      • 11.3.1.2 Asia Pacific Services Market by Country
    • 11.3.2 Asia Pacific Healthcare Chatbot Market by Application
      • 11.3.2.1 Asia Pacific Medical Data Repositories Market by Country
      • 11.3.2.2 Asia Pacific Automated patient support Market by Country
      • 11.3.2.3 Asia Pacific Personal Assistance Market by Country
      • 11.3.2.4 Asia Pacific Other Application Market by Country
    • 11.3.3 Asia Pacific Healthcare Chatbot Market by Deployment
      • 11.3.3.1 Asia Pacific Cloud Market by Country
      • 11.3.3.2 Asia Pacific On-Premises Market by Country
    • 11.3.4 Asia Pacific Healthcare Chatbot Market by End-use
      • 11.3.4.1 Asia Pacific Healthcare providers Market by Country
      • 11.3.4.2 Asia Pacific Patients Market by Country
      • 11.3.4.3 Asia Pacific Insurance companies Market by Country
      • 11.3.4.4 Asia Pacific Other End-use Market by Country
    • 11.3.5 Asia Pacific Healthcare Chatbot Market by Country
      • 11.3.5.1 China Healthcare Chatbot Market
        • 11.3.5.1.1 China Healthcare Chatbot Market by Component
        • 11.3.5.1.2 China Healthcare Chatbot Market by Application
        • 11.3.5.1.3 China Healthcare Chatbot Market by Deployment
        • 11.3.5.1.4 China Healthcare Chatbot Market by End-use
      • 11.3.5.2 Japan Healthcare Chatbot Market
        • 11.3.5.2.1 Japan Healthcare Chatbot Market by Component
        • 11.3.5.2.2 Japan Healthcare Chatbot Market by Application
        • 11.3.5.2.3 Japan Healthcare Chatbot Market by Deployment
        • 11.3.5.2.4 Japan Healthcare Chatbot Market by End-use
      • 11.3.5.3 India Healthcare Chatbot Market
        • 11.3.5.3.1 India Healthcare Chatbot Market by Component
        • 11.3.5.3.2 India Healthcare Chatbot Market by Application
        • 11.3.5.3.3 India Healthcare Chatbot Market by Deployment
        • 11.3.5.3.4 India Healthcare Chatbot Market by End-use
      • 11.3.5.4 South Korea Healthcare Chatbot Market
        • 11.3.5.4.1 South Korea Healthcare Chatbot Market by Component
        • 11.3.5.4.2 South Korea Healthcare Chatbot Market by Application
        • 11.3.5.4.3 South Korea Healthcare Chatbot Market by Deployment
        • 11.3.5.4.4 South Korea Healthcare Chatbot Market by End-use
      • 11.3.5.5 Singapore Healthcare Chatbot Market
        • 11.3.5.5.1 Singapore Healthcare Chatbot Market by Component
        • 11.3.5.5.2 Singapore Healthcare Chatbot Market by Application
        • 11.3.5.5.3 Singapore Healthcare Chatbot Market by Deployment
        • 11.3.5.5.4 Singapore Healthcare Chatbot Market by End-use
      • 11.3.5.6 Malaysia Healthcare Chatbot Market
        • 11.3.5.6.1 Malaysia Healthcare Chatbot Market by Component
        • 11.3.5.6.2 Malaysia Healthcare Chatbot Market by Application
        • 11.3.5.6.3 Malaysia Healthcare Chatbot Market by Deployment
        • 11.3.5.6.4 Malaysia Healthcare Chatbot Market by End-use
      • 11.3.5.7 Rest of Asia Pacific Healthcare Chatbot Market
        • 11.3.5.7.1 Rest of Asia Pacific Healthcare Chatbot Market by Component
        • 11.3.5.7.2 Rest of Asia Pacific Healthcare Chatbot Market by Application
        • 11.3.5.7.3 Rest of Asia Pacific Healthcare Chatbot Market by Deployment
        • 11.3.5.7.4 Rest of Asia Pacific Healthcare Chatbot Market by End-use
  • 11.4 LAMEA Healthcare Chatbot Market
    • 11.4.1 LAMEA Healthcare Chatbot Market by Component
      • 11.4.1.1 LAMEA Software Market by Country
      • 11.4.1.2 LAMEA Services Market by Country
    • 11.4.2 LAMEA Healthcare Chatbot Market by Application
      • 11.4.2.1 LAMEA Medical Data Repositories Market by Country
      • 11.4.2.2 LAMEA Automated patient support Market by Country
      • 11.4.2.3 LAMEA Personal Assistance Market by Country
      • 11.4.2.4 LAMEA Other Application Market by Country
    • 11.4.3 LAMEA Healthcare Chatbot Market by Deployment
      • 11.4.3.1 LAMEA Cloud Market by Country
      • 11.4.3.2 LAMEA On-Premises Market by Country
    • 11.4.4 LAMEA Healthcare Chatbot Market by End-use
      • 11.4.4.1 LAMEA Healthcare providers Market by Country
      • 11.4.4.2 LAMEA Patients Market by Country
      • 11.4.4.3 LAMEA Insurance companies Market by Country
      • 11.4.4.4 LAMEA Other End-use Market by Country
    • 11.4.5 LAMEA Healthcare Chatbot Market by Country
      • 11.4.5.1 Brazil Healthcare Chatbot Market
        • 11.4.5.1.1 Brazil Healthcare Chatbot Market by Component
        • 11.4.5.1.2 Brazil Healthcare Chatbot Market by Application
        • 11.4.5.1.3 Brazil Healthcare Chatbot Market by Deployment
        • 11.4.5.1.4 Brazil Healthcare Chatbot Market by End-use
      • 11.4.5.2 Argentina Healthcare Chatbot Market
        • 11.4.5.2.1 Argentina Healthcare Chatbot Market by Component
        • 11.4.5.2.2 Argentina Healthcare Chatbot Market by Application
        • 11.4.5.2.3 Argentina Healthcare Chatbot Market by Deployment
        • 11.4.5.2.4 Argentina Healthcare Chatbot Market by End-use
      • 11.4.5.3 UAE Healthcare Chatbot Market
        • 11.4.5.3.1 UAE Healthcare Chatbot Market by Component
        • 11.4.5.3.2 UAE Healthcare Chatbot Market by Application
        • 11.4.5.3.3 UAE Healthcare Chatbot Market by Deployment
        • 11.4.5.3.4 UAE Healthcare Chatbot Market by End-use
      • 11.4.5.4 Saudi Arabia Healthcare Chatbot Market
        • 11.4.5.4.1 Saudi Arabia Healthcare Chatbot Market by Component
        • 11.4.5.4.2 Saudi Arabia Healthcare Chatbot Market by Application
        • 11.4.5.4.3 Saudi Arabia Healthcare Chatbot Market by Deployment
        • 11.4.5.4.4 Saudi Arabia Healthcare Chatbot Market by End-use
      • 11.4.5.5 South Africa Healthcare Chatbot Market
        • 11.4.5.5.1 South Africa Healthcare Chatbot Market by Component
        • 11.4.5.5.2 South Africa Healthcare Chatbot Market by Application
        • 11.4.5.5.3 South Africa Healthcare Chatbot Market by Deployment
        • 11.4.5.5.4 South Africa Healthcare Chatbot Market by End-use
      • 11.4.5.6 Nigeria Healthcare Chatbot Market
        • 11.4.5.6.1 Nigeria Healthcare Chatbot Market by Component
        • 11.4.5.6.2 Nigeria Healthcare Chatbot Market by Application
        • 11.4.5.6.3 Nigeria Healthcare Chatbot Market by Deployment
        • 11.4.5.6.4 Nigeria Healthcare Chatbot Market by End-use
      • 11.4.5.7 Rest of LAMEA Healthcare Chatbot Market
        • 11.4.5.7.1 Rest of LAMEA Healthcare Chatbot Market by Component
        • 11.4.5.7.2 Rest of LAMEA Healthcare Chatbot Market by Application
        • 11.4.5.7.3 Rest of LAMEA Healthcare Chatbot Market by Deployment
        • 11.4.5.7.4 Rest of LAMEA Healthcare Chatbot Market by End-use

Chapter 12. Company Profiles

  • 12.1 Ada Health GmbH
    • 12.1.1 Company Overview
    • 12.1.2 Recent strategies and developments:
      • 12.1.2.1 Product Launches and Product Expansions:
  • 12.2 Healthily LTD.
    • 12.2.1 Company Overview
  • 12.3 Babylon Healthcare Services Ltd. (eMed)
    • 12.3.1 Company Overview
    • 12.3.2 Recent strategies and developments:
      • 12.3.2.1 Product Launches and Product Expansions:
  • 12.4 Woebot Labs, Inc. (Woebot Health)
    • 12.4.1 Company Overview
  • 12.5 TECKEL MEDICAL S.L. (Mediktor)
    • 12.5.1 Company Overview
  • 12.6 HealthTap, Inc.
    • 12.6.1 Company Overview
    • 12.6.2 Recent strategies and developments:
      • 12.6.2.1 Product Launches and Product Expansions:
  • 12.7 Luka, Inc. (Replika)
    • 12.7.1 Company Overview
  • 12.8 K Health, Inc.
    • 12.8.1 Company Overview
    • 12.8.2 Recent strategies and developments:
      • 12.8.2.1 Product Launches and Product Expansions:
  • 12.9 BytePlus Pte Ltd.
    • 12.9.1 Company Overview
  • 12.10. Fabric Labs, Inc. (Fabric)
    • 12.10.1 Company Overview

Chapter 13. Winning Imperatives of Healthcare Chatbot Market

»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦